Add-on drugs for preventing adverse effects of cannabinoid therapy (Ref. TEC0045)

An add-on drug for preventing adverse effects (anxiety disorders) of cannabinoid therapies without altering the analgesic and anxiolytic beneficial effects of THC. Main advantages of this technology:

  • Administration of the add-on drug prevents the negative effects produced by the psychoactive component of cannabis Δ9-THC whereas it does not alter the analgesic and anxiolytic beneficial effects of THC.
  • High potential of the cannabinoid therapies in different pathologies.

Technology ready for a licensee or partner to continue the preclinical experiments and start clinical development.

Ref: 
TEC0045